J Venom Res (2021), Vol 11, 1-6
Published online: 06 January 2021
Deb Prasad Pandey1,2, 3,*, Budhan Chaudhary4, Bhola Ram Shrestha5
1School of Medicine and Public Health, Faculty of Health and Medicine, The University of Newcastle, Australia
2Department of Veterinary Microbiology and Parasitology, Agriculture and Forestry University, Rampur, Chitwan, Nepal
3Institute for Social and Environmental Research, Fulbari, Chitwan, Nepal
4Department of Zoology, Birendra Multiple Campus, Tribhuvan University, Bharatpur, Chitwan, Nepal
5National Academy of Medical Sciences, Bir Hospital, Kathmandu, Nepal, (current address: Karnali Academy Of Health Sciences, Nepal)
*Correspondence to: Deb Prasad Pandey, Email: firstname.lastname@example.org, Tel: +977 9845055137
Received: 14 September 2020 | Revised: 19 December 2020 | Accepted: 31 December 2020
© Copyright The Author(s). This is an open access article, published under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0). This license permits non-commercial use, distribution and reproduction of this article, provided the original work is appropriately acknowledged, with correct citation details.
We document inadequately diagnosed coagulopathy (potential to be life threatening) due to Ovophis monticola bite. Although its bites are common in the hills of Nepal, associated envenomations have not been documented elaborately. Herein, we present the clinical and treatment details of a proven O. monticola bite and areas where it may pose the risk of envenomations (suggesting huge populations in Asia to be vulnerable to its bites). Its envenomation was managed symptomatically with several non-evidence-based interventions. Since no specific pitviper antivenom is available in Nepal yet, managing coagulopathy associated to O. monticola envenomation is still challenging. This case emphasizes the need of developing the standard protocol for the diagnosis and management of pitviper bites and study of effectiveness of the available pitviper antivenoms until specific pitviper antivenom is available. Further, the demonstrated distribution localities of this species may have implications for snakebite prevention and designing and distribution of the effective antivenoms.
KEYWORDS: Coagulation, coagulopathy, complex regional pain syndrome, hemotoxicity, pain, pitviper, snakebite, venom-induced consumption coagulopathy